Results 41 to 50 of about 102,707 (301)

Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial.

The Lancet Gastroenterology and Hepatology, 2022
BACKGROUND To achieve WHO targets for the elimination of hepatitis C virus (HCV) as a public threat, an increased uptake of HCV treatment among people who inject drugs (PWID) is urgently needed.
A. Litwin, Paula J Lum, L. Taylor, S. Mehta, J. Tsui, Judith Feinberg, A. Kim, B. Norton, Moonseong Heo, J. Arnsten, Paul Meissner, A. Karasz, M. McKee, J. Ward, Nirah Johnson, I. Pericot-Valverde, L. Agyemang, Ellen Stein, Aurielle M Thomas, C. Borsuk, Kendra L. Blalock, S. Wilkinson, Katherine Wagner, Jillian M. Roche, Cristina Murray-Krezan, Jessica L. Anderson, Vanessa Jacobsohn, A. Luetkemeyer, O. Falade-Nwulia, K. Page   +29 more
semanticscholar   +1 more source

Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework

Journal of Virus Eradication, 2018
The current global burden of hepatitis C (HCV) is estimated at 71 million people. The World Health Organization (WHO) has stated that HCV could be eliminated as a public health threat by 2030.
Ste.phanie Popping, Manal El-Sayed, Jordan Feld, Angelos Hatzakis, Margaret Hellard, Olufunmilayo Lesi, Michael Ninburg, John Ward, Charles Boucher   +8 more
doaj   +1 more source

The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis

Substance Abuse Treatment, Prevention, and Policy, 2022
Background One of the most important routes of HIV transmission is through injections of drugs, and this group, due to unawareness of their infection, causes the spread of HIV. The coexistence of other opportunistic infections and diseases with HIV among
Negin Farhadian, Behzad Karami Matin, Vahid Farnia, Mohammad Hossein Zamanian, Farid Najafi, Maryam Farhadian   +5 more
doaj   +1 more source

Hepatitis B vaccination for people who inject drugs

The Lancet, 2015
Tim Weaver and colleagues’ Article is the fourth randomised controlled trial to show that contingency management can increase hepatitis B vaccination completion in people who inject drugs. Although the completion rates reported in the study by Weaver and colleagues (9%, 45%, and 49%) are consistent with previous observational research, which has ...
Vivian D, Hope, Sema, Mandal, Katelyn J, Cullen, Koye, Balogun, Fortune, Ncube   +4 more
openaire   +5 more sources

Challenges posed by COVID‐19 to people who inject drugs and lessons from other outbreaks

Journal of the International AIDS Society, 2020
In light of the COVID‐19 pandemic, considerable effort is going into identifying and protecting those at risk. Criminalization, stigmatization and the psychological, physical, behavioural and economic consequences of substance use make people who inject ...
T. I. Vasylyeva, P. Smyrnov, S. Strathdee, S. Friedman   +3 more
semanticscholar   +1 more source

The impact of peer support on testing, linkage to and engagement in HIV care for people who inject drugs in Indonesia: qualitative perspectives from a community-led study

Harm Reduction Journal, 2022
Introduction People who use, including those who inject, drugs in Indonesia are disproportionately affected by HIV, but tend to be diagnosed at a late stage of infection, delay initiation to and have poor rates of retention in antiretroviral treatment ...
Arif Rachman Iryawan, C. Stoicescu, Faisyal Sjahrial, Kuntanto Nio, Alexa Dominich   +4 more
semanticscholar   +1 more source

HIV prevalence, related risk behaviors, and correlates of HIV infection among people who use drugs in Cambodia

BMC Infectious Diseases, 2018
Background Although HIV prevalence in Cambodia has declined to 0.6% among the general population, the prevalence remains high among female sex workers (14.0%) and men who have sex with men (2.3%).
Heng Sopheab, Chhorvann Chhea, Sovannary Tuot, Jonathan A. Muir   +3 more
doaj   +1 more source

Reasons for Not Using Condoms by People Who Inject Drugs in Iran; Results from a Conventional Content Analysis in 2018

مجله اپیدمیولوژی ایران, 2021
Background and Objectives: This qualitative study was conducted to identify reasons for not using condoms by people who inject drugs (PWID) in Iran.
M Faghir Gangi, Ali Mirzazadeh, H Rastad, S Nedjat, A Rahimi-Movaghar, K Yazdani   +5 more
doaj  

“We want everything in a one-stop shop”: acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for Black people who inject drugs

Harm Reduction Journal, 2022
Introduction A recent surge in HIV outbreaks, driven by the opioid and stimulant use crises, has destabilized our progress toward targets set forth by Ending the HIV Epidemic: A Plan for America for the high-priority community of people who inject drugs (
T. Bartholomew, Barbara Andraka-Cristou, Rachel Totaram, Shana Harris, Susanne Doblecki-Lewis, Lily Ostrer, D. Serota, David W. Forrest, Teresa A. Chueng, E. Suarez, H. Tookes   +10 more
semanticscholar   +1 more source

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs [PDF]

Clinical Infectious Diseases, 2013
Boceprevir and telaprevir are inhibitors and substrates of the cytochrome P450 3A4 family. With the use of these HCV protease inhibitors as part of standard therapy for chronic hepatitis C genotype 1 infection, drug-drug interactions with multiple medications being inductors, inhibitors, or substrates of cytochrome P450 3A4 can be expected.
Stefan, Mauss, Hartwig, Klinker
openaire   +2 more sources